Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC

被引:54
|
作者
Zhang, Hanwen [1 ]
Moroz, Maxim A. [1 ]
Serganova, Inna [1 ]
Ku, Thomas [2 ]
Huang, Ruimin [1 ]
Vider, Jelena [1 ]
Maecke, Helmut R. [3 ]
Larson, Steven M. [2 ,4 ]
Blasberg, Ronald [1 ,2 ,4 ]
Smith-Jones, Peter M. [2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[3] Univ Basel Hosp, Dept Radiol, CH-4031 Basel, Switzerland
[4] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA
关键词
reporter gene; hSSTr2; Ga-68-DOTATOC; PET; PROLIFERATION IN-VITRO; NEUROENDOCRINE TUMORS; CELLS; ANALOGS; GROWTH; PET; ANGIOGENESIS; INHIBITION; THERAPY; SST(2);
D O I
10.2967/jnumed.110.079004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The human somatostatin receptor subtype 2 (hSSTr2)-Ga-68-DOTATOC reporter system has several attractive features for potential translation to human studies. These include a low expression of hSSTr2 in most organs, a rapid internalized accumulation of Ga-68-DOTATOC in the SSTr2-expressing cells, and a rapid excretion of unbound radioligand by the renal system. We performed a series of in vitro and in vivo validation studies of this reporter system. Methods: A retroviral vector containing a dual reporter, pQCXhSSTr2-IRES-GFP (IRES: internal ribosome entry site; GFP: green fluorescent protein), was constructed and transduced into Jurkat, C6, and U87 cells. Stably transduced reporter cells were characterized in vitro using optical and radiometric methods. Multiple tumor-bearing mice were evaluated with Ga-68-DOTATOC PET studies. Results: The dual-reporter genes were incorporated into all tumor cell lines, and their expression levels were confirmed by fluorescence-activated cell sorting (FACS), GFP visualization, and reverse-transcriptase polymerase chain reaction (RT-PCR) analysis for hSSTr2. In vitro, hSSTr2 cell membrane expression was 36,000, 280,000, and 1,250,000 copies per cell for the SSTR2-transfected Jurkat, U87, and C6 cell lines. Small-animal PET of Ga-68-DOTATOC in tumor-bearing mice demonstrated that the in vivo uptake of this radioligand was directly proportional to the in vitro expression of hSSTr2. The in vivo uptake of Ga-68-DOTATOC, at 2 h after injection, was low in all organs except the kidneys (7.8 percentage of injected dose per gram [%ID/g]) and as high as 15.2 %ID/g in transduced C6 tumors. The corresponding transduced-to-nontransduced tumor uptake ratio was 64, and the tumor-to-muscle uptake ratio was around 500. Conclusion: Ga-68-DOTATOC is an excellent specific ligand for this hSSTr2 reporter system and for hSSTr2 reporter gene PET. Because DOTATOC has undergone extensive clinical testing, this human reporter system has the potential for translation to human studies.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 50 条
  • [1] Imaging somatostatin receptor subtype-2 gene transduced cells with [67/68Ga]DOTATOC
    Zhang, Hanwen
    Moroz, Maxim A.
    Serganova, Inna
    Ku, Thomas
    Smith-Jones, Peter
    Blasberg, Ronald
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] Imaging of somatostatin receptor subtype 2 in advanced hepatocellular carcinoma by 68Ga-DOTATOC PET
    Freesmeyer, M.
    Schulz, St.
    Knoesel, T.
    Settmacher, U.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (03): : N17 - N18
  • [3] Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data
    Hofmann, M
    Maecke, H
    Börner, AR
    Weckesser, E
    Schöffski, P
    Oei, ML
    Schumacher, J
    Henze, M
    Heppeler, A
    Meyer, GJ
    Knapp, WH
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) : 1751 - 1757
  • [4] The Human Somatostatin 2 Receptor for Ga-68-DOTATATE Reporter Gene Imaging
    Rinaldi, V.
    Aurilio, M.
    Di Tommaso, M.
    Cotugno, G.
    Auricchio, A.
    Lastoria, S.
    Aloj, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S389 - S389
  • [5] Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data
    M. Hofmann
    H. Maecke
    A. Börner
    E. Weckesser
    P. Schöffski
    M. Oei
    J. Schumacher
    M. Henze
    A. Heppeler
    G. Meyer
    W. Knapp
    [J]. European Journal of Nuclear Medicine, 2001, 28 : 1751 - 1757
  • [6] Effects of 68Ga-DOTATOC specific activity on somatostatin receptor quantitation
    Heidari, Pedram
    Deng, Francis
    Esfahani, Shadi
    Larimer, Benjamin
    Mahmood, Umar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level: Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
    Boy, C.
    Ezziddin, S.
    Rosenbaum-Krumme, S.
    Nagarajah, J.
    Fichtner, C.
    Brandau, W. W.
    Lauenstein, T.
    Lahner, H.
    Sheu, S.
    Bockisch, A.
    Poeppel, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S411 - S411
  • [8] Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT
    Miederer, Matthias
    Seidl, Stefan
    Buck, Andreas
    Scheidhauer, Klemens
    Wester, Hans-Juergen
    Schwaiger, Markus
    Perren, Aurel
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (01) : 48 - 52
  • [9] Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT
    Matthias Miederer
    Stefan Seidl
    Andreas Buck
    Klemens Scheidhauer
    Hans-Jürgen Wester
    Markus Schwaiger
    Aurel Perren
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 48 - 52
  • [10] Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68Ga-DOTATOC PET
    Henze, M
    Schuhmacher, J
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Mäcke, HR
    Eisenhut, M
    Haberkorn, U
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) : 466 - 466